From this CPD module you will learn:
- Recent changes in legislation surrounding cannabis-based medicines, and associated guidance on prescribing
- The status of recreational cannabis
- Information on undesirable effects and interactions
- What advice to give customers seeking products related to cannabis, including CBD oils
Download a printable PDF of this module – including the five-minute test – here.
In June 2018, the UK Home Office launched a review into the scheduling of cannabis and cannabis-based products for medicinal purposes. There were two parts to this work:
- whether there was evidence supporting the medicinal use of cannabis-based products (led by UK chief medical advisor Sally Davies)
- whether cannabis-based products should be moved from Schedule 1 to Schedule 2 of the Misuse of Drugs regulations 2001 (led by the Advisory Council on the Misuse of
